Form 8-K · Current report
Johnson Controls 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0000833444
- Accession no.
- 0000833444-26-000101
Summary
Johnson Controls International plc reported fiscal fourth-quarter and full-year 2026 results, with Q4 sales rising 10% to $7.1 billion and organic sales rising 12%, and initiated fiscal 2027 guidance. CEO Joakim Weidemanis said the company finished fiscal 2026 with momentum and entered fiscal 2027 with confidence, citing record backlog and sustained customer demand.
Key points
- Q4 GAAP EPS was $1.60 and adjusted EPS was $1.66.
- Q4 orders rose 44% organically year-over-year and backlog rose 43% organically to $23.0 billion.
- FY2027 first-quarter guidance calls for organic sales growth of 12%–14%, operating leverage of 30%–35%, and adjusted EPS of $1.15–$1.20.
- FY2027 full-year guidance calls for organic sales growth of 11%–12%, operating leverage of 30%+, adjusted EPS of $6.15–$6.30, and adjusted free cash flow conversion of ~95%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. On October 27, 2026, Johnson Controls International plc (the "Company") issued a press release containing information about the Company’s results of operations for the three months and fiscal year ended September 30, 2026. A copy of this press release is furnished as Exhibit 99.1 and incorporated by reference in this Item 2.02. Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release issued by Johnson Controls International plc, dated October 27, 2026, relating to the Company’s results of operations. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.